Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
14.47 USD | -0.34% | +1.12% | +13.49% |
02-09 | HC Wainwright Adjusts Price Target on Curis to $26 From $51, Maintains Buy Rating | MT |
02-08 | Curis, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Sales 2024 * | 8.61M 689M | Sales 2025 * | 8.96M 718M | Capitalization | 85.29M 6.83B |
---|---|---|---|---|---|
Net income 2024 * | -49M -3.92B | Net income 2025 * | -54M -4.32B | EV / Sales 2024 * | 9.9 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 9.52 x |
P/E ratio 2024 * |
-2.33
x | P/E ratio 2025 * |
-2.81
x | Employees | 49 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 99.82% |
Latest transcript on Curis, Inc.
1 day | -0.34% | ||
1 week | +1.12% | ||
Current month | +33.12% | ||
1 month | +33.12% | ||
3 months | +40.62% | ||
6 months | +267.26% | ||
Current year | +13.49% |
Managers | Title | Age | Since |
---|---|---|---|
James Dentzer
CEO | Chief Executive Officer | 57 | 28/03/16 |
Diantha Duvall
DFI | Director of Finance/CFO | 52 | 25/07/22 |
Chief Tech/Sci/R&D Officer | - | 02/01/22 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 71 | 31/10/03 | |
Chairman | 82 | 13/02/00 | |
James Dentzer
CEO | Chief Executive Officer | 57 | 28/03/16 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.01% | 0 M€ | 0.00% | - | |
0.01% | 2 M€ | -.--% |
Date | Price | Change | Volume |
---|---|---|---|
26/04/24 | 14.47 | -0.34% | 10,913 |
25/04/24 | 14.52 | -1.69% | 10,246 |
24/04/24 | 14.77 | -1.60% | 4,734 |
23/04/24 | 15.01 | +1.08% | 5,785 |
22/04/24 | 14.85 | +3.77% | 21,156 |
Delayed Quote Nasdaq, April 26, 2024 at 09:00 pm
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+13.49% | 85.29M | |
+1.51% | 42.75B | |
+49.22% | 41.61B | |
+8.57% | 41.34B | |
-12.36% | 26.59B | |
+8.92% | 25.49B | |
-25.13% | 18.12B | |
+29.17% | 12.24B | |
-3.12% | 11.76B | |
+6.35% | 11B |
- Stock Market
- Equities
- CRIS Stock